Developments in the Design, Conduct, and Reporting of Child Health Trials

Ami Baba1, Alex Aregbesola2,3, Patrina H Y Caldwell4

  • 1Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.

Pediatrics
|June 4, 2024
PubMed

Insights

Progress in pediatric clinical trial methods is slow, despite efforts by Standards for Research (StaR) in Child Health. Emerging trends like patient engagement and adaptive designs offer future improvements for child health research.

Area of Science:

  • Pediatric Clinical Trials
  • Child Health Research Methods

Background:

  • The Standards for Research (StaR) in Child Health network published initial standards in 2012 to improve pediatric clinical trials.
  • A review of 247 publications highlighted research practices that add value and reduce waste in child health research.

Purpose of the Study:

  • To assess progress in key pediatric trial methods areas.
  • To identify emerging trends to enhance the clinical usefulness of pediatric trials.

Main Methods:

  • Review of publications from StaR Child Health authors.
  • Assessment of progress in areas including consent, bias, data monitoring, sample size, outcomes, and age groups.
  • Exploration of emerging trends and implementation science approaches.

Main Results:

  • Meaningful change has occurred, but measurable progress in pediatric trial methods remains slow.
  • Key areas assessed include consent, bias, data monitoring, sample size, outcomes, and age groups.

Conclusions:

  • Emerging trends such as patient engagement, Bayesian statistics, adaptive designs, and platform trials can advance pediatric research.
  • Implementation science offers a framework for improving the design, conduct, and reporting of child health research.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.7K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
211
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
111